Kern Pharma mulls new acquisitions
Catalan Economy
26 Jun 2009
Kern pharma, a unit of pharmaceutical group indukern, has announced that it is looking into new acquisitions to grow in catalonia and strengthen its presence in international markets. indukern ceo raul diaz-varela confirmed that its company is interested in acquiring the solvay pharma plant in parets del vallès or one of labiana factories. kern facilities in terrassa could reach its maximum production capacity in less than two years, he added. the group is also studying acquisitions in france and italy to strengthen its european business. in 2008, indukern posted revenue of 550 million euros, up 7.8% over the previous year.
source: expansión catalunya 25/06/09
Related news and success stories.
-
25 Apr 2024
Catalonia is the third EU region to attract the most European funding for research and innovation projects, with over €1,000M
-
05 Apr 2024
Catalonia launches a new Master's in Semiconductors and Microelectronic Design
-
05 Apr 2024
Barcelona boosts business connectivity with new flights to Miami
-
26 Mar 2024
The children's product sector in Catalonia has a turnover of over €4.4 billion